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T he Fontan procedure and its modifications havebeen applied to nearly all forms of single ventricle
cardiac lesions. A more thorough understanding of
post-Fontan physiology, modifications in surgical tech-
nique, and advances in perioperative care have led to
improved outcomes. The average early survival after
the Fontan procedure has improved from 75% to greater
than 90% over the past 20 years.1-5 Despite improved
overall survival, many authors still consider specific
cardiac lesions to carry an elevated risk of early postop-
erative mortality. Usually included in this higher risk
category are patients with hypoplastic left heart syn-
drome (HLHS).6-9
Objectives: The purpose of this study was to review a large, single institu-
tional experience with the Fontan procedure for patients with hypoplastic left
heart syndrome. 
Methods: One hundred consecutive patients with “classic” hypoplastic left
heart syndrome underwent Fontan palliation between February 1992 and
April 1998. Patient demographic, morphologic, and procedural variables
were examined and analyzed. In particular, two different surgical techniques
were used: technique I (February 1992 to December 1995) employed car-
diopulmonary bypass and moderate systemic hypothermia, and technique II
(December 1995 to April 1998), profound hypothermia and circulatory
arrest. A retrospective review of medical records was performed and vari-
ables were examined and analyzed.
Results: Hospital survival for the entire cohort was 89% (95% CI 83%-
95%). The technique of operation, cardiopulmonary bypass time, and aor-
tic crossclamp time were each strongly associated with survival. Survival
for patients treated by technique I was 79% (95% CI 68-91%; n = 48) and
for those treated by technique II, 98% (95% CI 94%-100%; n = 52).
Cardiopulmonary bypass and crossclamp times were also highly correlat-
ed with time to extubation and length of intensive care unit stay.
Preoperative pulmonary artery pressure was correlated with survival; pre-
operative oxygen saturation, right atrial pressure, pulmonary vascular
resistance, pulmonary artery size, extent of aortopulmonary artery collat-
erals, and echocardiographic estimates of ventricular function and tricus-
pid regurgitation were not correlated with survival.
Conclusions: Our recent experience with Fontan palliation for patients with
hypoplastic left heart syndrome suggests that it is attended by low perioper-
ative mortality. The precise operative technique used appears to be an impor-
tant determinant of outcome, with the duration of cardiopulmonary bypass
and crossclamping being particularly significant. (J Thorac Cardiovasc Surg
2000;119:1110-8)
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Certain preoperative and intraoperative variables,
aside from the basic cardiac morphology, have been
identified as important risk factors for early postopera-
tive mortality after Fontan palliation. These include
elevated pulmonary artery pressure and resistance, ven-
tricular dysfunction, systemic atrioventricular valve
regurgitation, longer cardiopulmonary bypass (CPB)
time, and significant pulmonary artery distortion.6,7 In
addition, there is a sense that systemic–pulmonary
artery collateral blood vessels, by providing pulmonary
arterial flow that competes with systemic venous
return, may also increase morbidity and mortality.10,11
The purpose of this study was to review our experience
with the Fontan procedure performed for patients with
HLHS in an effort to ascertain whether these and other
perioperative variables influenced patient outcome
(hospital survival, duration of intubation, length of time
in the intensive care unit, and length of total hospital
stay). Although these techniques are used in all of our
patients with various forms of univentricular heart, the
cohort of patients with HLHS was chosen since it rep-
resents the largest and most homogeneous group at our
institution. A significant change in surgical technique
for the Fontan operation occurred approximately
halfway through this series, and patient outcomes were
therefore also related to the type of surgical manage-
ment used.
Methods
Patients. This is a retrospective study of 100 consecutive
patients with HLHS who underwent a Fontan procedure
between February 1992 and April 1998. Only patients with
“classic” HLHS (aortic valve atresia or hypoplasia and a right
ventricle–dependent circulation) were included.12 Patients with
other single right ventricle lesions, such as an unbalanced atrio-
ventricular septal defect and left ventricular hypoplasia or dou-
ble-outlet right ventricle with mitral atresia, were excluded. All
patients had previously undergone neonatal Norwood pallia-
tion followed by stage 2 palliation consisting of a bidirectional
Glenn (BDG) or hemi-Fontan procedure (HFP).
Operative technique. The final anatomy of the Fontan pal-
liation was essentially the same in all the patients in this
report: a total cavopulmonary connection with a polytetraflu-
oroethylene* intra-atrial lateral tunnel, with a 4-mm fenestra-
tion within this baffle. However, two significantly different
surgical techniques were used to effect this palliation:
Technique I. Forty-eight patients operated on between
February 1992 and December 1995 underwent the Fontan
procedure with CPB, bicaval venous cannulation, and moder-
ate systemic hypothermia (28°C). All patients who had
undergone a BDG procedure13,14 for stage 2 palliation (n =
36) were included in this group, as well as 12 patients whose
stage 2 palliation was an HFP.15 The right pulmonary artery
and the cephalad aspect of the right atrium were mobilized.
Incisions in the inferior aspect of the right pulmonary artery
and in the superior portion of the right atrium were fashioned.
The caudal aspect of the right pulmonary artery and right atri-
um were connected, creating the floor of the new atriopul-
monary connection. A lateral tunnel (polytetrafluoroethyl-
ene) was then constructed incorporating the orifice of the
inferior vena cava, as well as the new atriopulmonary con-
nection. A 4-mm fenestration (punch or adjustable snare) was
placed within the baffle.
Technique II. Fifty-two patients operated on between
December 1995 and April 1998 underwent the Fontan pro-
cedure with single right atrial venous cannulation, pro-
found hypothermia, and deep hypothermic circulatory
arrest as previously described.16 Minimal dissection of the
cardiac structures was performed, and the pulmonary arter-
ies and venae cavae were not exposed. All patients in this
group had previously undergone an HFP as their stage 2
palliation. A right atriotomy anterior to the crista terminalis
was fashioned, the atrial septal defect was enlarged as
needed, and the patch separating the atria from the pul-
monary arteries was excised. The branch pulmonary arter-
ies were sounded and calibrated with dilators to confirm
their size. A lateral tunnel incorporating the orifices of both
venae cavae was fashioned with polytetrafluoroethylene. A
4-mm diameter punch fenestration was placed in the baffle.
The anterior suture line was sewn to the edge of the atri-
otomy, avoiding the crista terminalis, completing the baf-
fle, and closing the atria. The remainder of the operative
procedure was identical to technique I.
Concurrent procedures included tricuspid valvuloplasty
(n = 14) and placement of a pulmonary artery stent (n = 13).
Tricuspid valvuloplasty was performed with standard tech-
niques of suture commissuroplasty and/or annuloplasty.17
Artificial annuloplasty rings were not used. A Palmaz stent
(generally sizes P-188 or P-308; Johnson & Johnson
Interventional Systems, Warren, NJ) was inserted into the left
pulmonary artery when diffusely hypoplastic or when expo-
sure of the branch pulmonary artery would have required
extensive dissection.
Modified ultrafiltration (MUF) was introduced in April of
1996 and thus was used only in patients undergoing tech-
nique II (all but 2 patients undergoing technique II were treat-
ed with MUF at the Fontan procedure). This technique has
been described elsewhere18,19 and was routinely performed
for 10 minutes after weaning from CPB.
Data acquisition. Demographic and other patient-related
data (eg, the occurrence of postoperative complications) were
obtained from hospital records. For patients operated on with
technique II, the CPB time does not include the period of cir-
culatory arrest. Survival is defined as survival to hospital dis-
charge.1 Lengths of stay in the intensive care unit and in the
hospital were chosen as end points that encompass other
potentially complicating factors, that is, the use of inotropic
agents and persistent pleural effusions.*W. L. Gore & Associates, Inc, Flagstaff, Ariz.
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Echocardiographic data. A single examiner who was blind-
ed to the remainder of the patient data reviewed preoperative 2-
dimensional and Doppler echocardiograms, which had been
obtained within 10 days of the Fontan procedure. Right ventric-
ular systolic function was qualitatively estimated to be normal,
mild to moderately depressed, or severely depressed. The mag-
nitude of tricuspid regurgitation was qualitatively estimated to
be none or trace, mild to moderate, or severe.
Cardiac catheterization hemodynamic data. The following
data were extracted from the pre-Fontan catheterization
record: mean right atrial (RAP) and pulmonary arterial (PAP)
pressures, pulmonary blood flow (PBF, calculated by the Fick
principle with the use of either measured or assumed oxygen
consumption), and systemic arterial oxygen saturation.
Pulmonary vascular resistance (PVR) was calculated by the
following formula: PVR (indexed) = (Mean PAP – Mean
RAP)/PBF (indexed).
Angiographic data. A single observer inspected cinean-
giograms of the pulmonary artery and ascending aorta.
Branch pulmonary artery diameters just proximal to the ori-
gins of the right and left upper lobe branches and the diame-
ter of the descending thoracic aorta at the diaphragm were
measured and used to calculate the McGoon ratio.20,21 The
magnitude of blood flow into the lungs from aortopulmonary
collaterals was judged by a semiquantitative estimate of the
amount of contrast material present in the pulmonary arteries
Table I.  Patient demographic data, preoperative characteristics, intraoperative variables, and outcomes shown for
the entire group and a comparison between subgroups (technique I and technique II)
Total group Technique I Technique II
(n = 100) (n = 48) (n = 52)
Preop and intraop Mean ± 95% CI Mean ± 95% CI Mean ± 95% CIP value P value
parametric data (range, n) (range, n) (range, n) (technique I vs II)
Age (mo)† 23.5 ± 1.2 (14-50, 100) 24.8 ± 2.1 (14-50, 48) 22.8 ± 1.2 (16-36, 52) .05
Weight (kg)† 10.7 ± 0.33 (7-17, 100) 11.0 ± 0.58 (7-17, 48) 10.4 ± 0.33 (8.5-13, 52) .09
SAS (%)† 83 ± 1.0 (68-89, 96) 83 ± 1.0 (68-89, 46) 83 ± 1.0 (76-89, 50) >.2
RAP (mm Hg)† 6.4 ± 0.52 (1-16, 90) 6.6 ± 0.79 (1-14, 45) 6.1 ± 0.8 (2-16, 43) >.2
PAP (mm Hg)† 11.5 ± 0.53 (7-18, 94) 11.7 ± 0.72 (7-17, 46) 11.9 ± 0.7 (7-18, 48) >.2
PVR (WU × m2)† 2.1 ± 0.23 (0.4-6.2, 80) 1.9 ± 0.35 (0.4-6.2, 41) 1.9 ± 0.4 (0.66-4.5, 39) .13
McGoon ratio† 1.49 ± 0.07 (0.86-2.11, 76) 1.42 ± 0.10 (0.86-2.11, 33) 1.53 ± 0.09 (0.93-2.1, 43) .11
CPB time (min) 84.8 ± 7.1 (43-196, 100) 115.4 ± 8.2 (67-196, 48) 56.6 ± 2.6 (43-90, 52) <.0001
Crossclamp time (min) 48.1 ± 3.4 (24-105, 100) 58.9 ± 5.2 (30-105, 48) 38.2 ± 2.2 (24-64, 52) <.0001
Circulatory arrest time (min) NA NA 31.1 ± 2.3 (14-57, 51) NA
Preop nonparametric data n (%) n (%) n (%)
Systolic function† n = 98 n = 47 n = 51 >.2*
Normal ventricular function 77 (79%) 37 (79%) 40 (78%)
Mild to moderate ventricular dysfunction 17 (17%) 8 (17%) 9 (18%)
Severe ventricular dysfunction 4 (4%) 2 (4%) 2 (4%)
Tricuspid regurgitation† n = 98 n = 47 n = 51 >.2*
No regurgitation 60 (61%) 30 (64%) 30 (59%)
Mild regurgitation 27 (28%) 12 (26%) 15 (29%)
Moderate regurgitation 6 (6%) 4 (9%) 2 (4%)
Severe regurgitation 5 (5%) 1 (2.1%) 4 (8%)
Collateral blood flow† (qualitative scale) n = 76 n = 34 n = 42 .0004*
0 10 (13%) 7 (21%) 3 (7%)
1 20 (26%) 15 (44%) 5 (12%)
2 25 (33%) 7 (21%) 18 (43%)
3 12 (16%) 2 (6%) 10 (24%)
4 6 (8%) 3 (9%) 3 (7%)
5 2 (3%) 0 (0%) 2 (5%)
6 1 (1%) 0 (0%) 1 (2%)
Outcome data
Survival 89 ± 6.1*** (100) 79 ± 11.5*** (48) 98 ± 3.8*** (52) .003*
Intubation 2** (1-31, 97) 3** (1-31, 47) 1** (0-6, 50) <.0001*
ICU stay 3** (1-144, 98) 5.5** (2-144, 48) 2** (1-8, 50) <.0001*
Hospital stay 13.5** (2-146, 96) 16** (2-146, 48) 10.5** (6-40, 48) <.0021*
CI, Confidence interval; NA, not applicable; SAS, systemic arterial saturation; RAP, right atrial pressure; PAP, pulmonary artery pressure; PVR, pulmonary vascular
resistance; WU, Wood units; CPB, cardiopulmonary bypass; ICU, intensive care unit.
*Statistical testing with Wilcoxon rank sum test. ** Median value (range, n). *** Percentage ± 95% CI (n).
†Preoperative values.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 119, Number 6
Mosca et al   1113
and veins after injection of contrast medium into the ascend-
ing aorta. An ordinal scale was developed that is roughly pro-
portional to the magnitude of collateral flow. For each lung, 0
= no contrast material seen in the pulmonary vessels, 1 =
barely detectable contrast material in the pulmonary vessels,
and 3 = relatively dense contrast material easily seen in the
large branch pulmonary arteries and veins. A score of 2 was
assigned when the amount of contrast material entering the
pulmonary vessels was intermediate in magnitude between 1
and 3. Each lung was scored and the scores were added
together (the maximum score was therefore 6).
Statistical analysis. Four outcome measures were evaluat-
ed in the postoperative period: survival, number of postoper-
ative days intubated, length of stay in the intensive care unit,
and length of hospital stay. For survival, bivariate analyses of
possible predictors were performed with χ2 for all categoric
variables (tricuspid regurgitation, right ventricular function,
and aortopulmonary collateral blood flow) and the Student t
test for all continuous variables. The number of days intubat-
ed postoperatively, the length of stay in the intensive care
unit, and the hospital length of stay were not normally dis-
tributed. Therefore, bivariate comparisons for each of these
variables were performed by means of the Wilcoxon rank
sum test. Additionally, these outcomes were each categorized
into binomial variables, either less than or equal to the 75th
percentile or greater than the 75th percentile. These binomial
variables were assessed by means of χ2 for all categoric pre-
dictor variables and the Student t test for all continuous pre-
dictor variables. Nonparametric, ordinal data were tested as a
bivariate model; 75% were chosen to be tested for each of
these variables. Multivariable models with the use of logistic
analyses were then composed for each outcome to investigate
independent outcome predictors. All data were stored in
Microsoft Excel and then analyzed with the SAS statistical
package (SAS Institute, Inc, Cary, NC).
Results 
Outcomes.  Table I summarizes patient demograph-
ics, preoperative characteristics, intraoperative vari-
ables, and outcomes for all patients considered togeth-
er and when segregated according to the technique used
for the Fontan procedure. Patients operated on by
means of technique II had better outcomes (better sur-
Table II.  Patient preoperative and intraoperative data as shown in survivors and nonsurvivors
Survivors Nonsurvivors
Parametric data Mean ± CI (range, n) Mean ± CI (range, n) P value
Age (mo)† 23.8 ± 1.3 (16-50, 89) 21.3 ± 2.5 (14-26, 11) >.2
Weight (kg)† 10.76 ± 0.30 (7-17, 89) 9.86 ± 0.85 (8.4-12, 11) .09
SAS (%)† 83 ± 1.0 (74-89, 85) 83 ± 4.0 (68-89, 11) >.2
RAP (mm Hg)† 6.2 ± 0.60 (1-16, 77) 7.6 ± 1.6 (2-10, 10) .12
PAP (mm Hg)† 11.3 ± 0.54 (7-18, 83) 13.3 ± 1.24 (10-17, 11) .02
PVR (WU × m2)† 2.1 ± 0.25 (0.4-6.2, 71) 2.2 ± 0.72 (0.72-3.5, 9) >.2
CPB time (min) 79.8 ± 7.0 (43-172, 89) 124.9 ± 19.5 (82-197, 11) <.0001
Crossclamp time (min) 46.5 ± 3.5 (24-105, 89) 61.2 ± 10.83 (35-87, 11) .008
McGoon ratio† 1.49 ± 0.07 (0.86-2.11, 69) 1.46 ± 0.20 (1.25-1.92, 7) >.2
Nonparametric data
Systolic function† n = 87 n = 11 >.2*
Normal ventricular function 67 (77%) 10 (91%)
Mild-moderate ventricular function 16 (18%) 1 (9%)
Severe ventricular dysfunction 4 (5%) 0 (0%)
Tricuspid regurgitation† n = 87 n = 11 >.2*
No regurgitation 54 (62%) 6 (54%)
Mild regurgitation 24 (28%) 3 (27%)
Moderate regurgitation 5 (6%) 1 (9%)
Severe regurgitation 4 (5%) 1 (9%)
Collateral blood flow† n = 67 n = 9 >.2*
0 9 (13%) 1 (11%)
1 16 (24%) 4 (45%)
2 23 (34%) 2 (22%)
3 11 (16%) 1 (11%)
4 5 (7.5%) 1 (11%)
5 2 (3%) 0 (0%)
6 1 (1.5%) 0 (0%)
Survival was significantly associated with shorter cardiopulmonary bypass and aortic crossclamp times. In addition, pulmonary artery pressure was also significant-
ly associated with survival, however the differences in pressures are likely clinically unimportant. CI, Confidence interval; SAS, systemic arterial saturation; RAP,
right atrial pressure; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance; WU, Wood units; CPB, cardiopulmonary bypass.
*Statistical testing with Wilcoxon rank sum test.
†Preoperative values.
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vival, a shorter length of time intubated, and a shorter
length of stay in the intensive care unit and the hospi-
tal) than those operated on with technique I. Although
the preoperative characteristics of the patients in the 2
groups were very similar, there was a statistically sig-
nificant difference in ages between the 2 groups of
patients, and the aortopulmonary collateral blood flow
“score” was significantly higher for patients undergo-
ing technique II (Table I). CPB and aortic crossclamp
times were both significantly shorter for the patients
operated on with technique II, suggesting that these
variables might account for the difference in outcomes
between the 2 groups.
Predictors of survival. Survival was also associat-
ed with lower preoperative pulmonary artery pressure
and shorter CPB and aortic crossclamp times (Table
II). Patients treated by technique I had an increased
risk of death by logistic modeling (odds ratio 13.3;
95% CI 1.6-108.6). The surgical method used for
stage 2 palliation was also a predictor of survival;
78% for BDG patients (95% CI 65%-91%) and 95%
for HFP patients (95% CI 90%-100%; P = .017), with
an increased risk of mortality associated with the use
of a BDG procedure as stage 2 palliation (odds ratio
3.6; 95% CI 1-13.4). However, because all patients
with a BDG shunt had been operated on with tech-
nique I, it is difficult to ascertain whether the reduced
mortality in technique II is related to the type of stage
2 palliation or to the Fontan operative technique (or
both) due to the high correlation of these 2 variables.
Subgroup analysis reveals that although most
patients undergoing technique I had previously
undergone a BDG shunt (n = 36), 12 patients in this
group had undergone an HFP as stage 2 palliation.
There was no significant difference in mortality
between patients treated by technique I who had
undergone a BDG and those who had an HFP (22%
vs 17% mortality, respectively; P = .682). In contrast,
patients treated by technique I who underwent an
HFP tended to have a higher mortality than patients
treated by technique II who underwent an HFP (17%
vs 2% mortality; P = .09), Therefore, the type of
technique used at the Fontan operation appears to be
a more important predictor of mortality than the type
of stage 2 palliation used.
Longer CPB time, longer aortic crossclamp time, and
surgical technique I were significantly associated with
longer intubation time and longer stay in the intensive
care unit (Tables III and IV). The total length of hospi-
tal stay was significantly longer in patients undergoing
technique I and in those with longer CPB times (Table
I and Table V).
Discussion
The Fontan procedure originally described for the
treatment of tricuspid atresia is now being applied for
the palliation of virtually all forms of univentricular
lesions. A few factors appear to influence survival,
including the diagnosis of HLHS, elevated pulmonary
artery pressure and/or resistance, pulmonary arterial
distortion, impaired ventricular function, and pro-
longed CPB times.1-9 In addition, aortopulmonary
collateral blood flow, by competing with venous
return, also seems to increase the chance of an unfa-
vorable outcome.10,11 Relatively little data pertaining
to the results of the Fontan procedure in patients with
HLHS are available regarding these possible risk fac-
tors. This analysis was undertaken to determine
whether these and other variables affected short-term
morbidity and mortality in a relatively homogeneous
patient population.
The care of patients with univentricular heart at our
institution has evolved over the past decade. Initially,
patients underwent neonatal palliation followed by a
Fontan procedure. As we realized the advantages of the
BDG procedure in increasing the effective pulmonary
blood flow and reducing the volume load on the single
ventricle, this became a routine part of our staged palli-
ation. The Fontan procedure then required construction
of an atriopulmonary connection and often augmenta-
tion of narrowed branch pulmonary arteries. These
operations were performed with bicaval venous cannu-
lation and moderate hypothermia, which required sig-
nificant CPB and aortic crossclamp times and occasion-
ally were complicated by phrenic nerve injury,
postoperative bleeding, and reduced pulmonary compli-
ance. These factors appeared to negatively affect the
outcome of our patients with single ventricle lesions.
The HFP was then used as a routine method to augment
the branch pulmonary arteries and provide a large
potential communication within the right atrial chamber
for the eventual lateral tunnel Fontan procedure. When
performed with a single atrial cannula and profound
hypothermia, use of an HFP as an intermediate-stage
procedure greatly facilitated the Fontan procedure by
reducing the time required for dissection of mediastinal
structures, markedly reduced phrenic nerve injury as a
complication, and made reconstructive work on the
branch pulmonary arteries rare. For this reason the lat-
ter technique has been adopted as our preferred method
of palliation of patients with single ventricle lesions.
Recognizing the potential deleterious effects of circula-
tory arrest, we have continued to develop our technique.
We currently use brief periods of complete circulatory
arrest (5-10 minutes) in association with very low flow
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bypass and venous return provided by nonocclusive
suckers to the CPB circuit.
Although the short-term survival of the patients in this
report (79%) is not as good as published reports of all
patients undergoing the Fontan procedure when viewed
as a whole, the survival of patients treated by technique II
(98%) compares favorably with the best reported results.4
Thus, the diagnosis of HLHS in itself does not militate
against low operative morbidity and mortality.
A marked improvement in morbidity and mortality
was observed between patients undergoing the Fontan
procedure with technique II as compared with tech-
nique I. The preoperative characteristics of the patients
in the 2 groups were very similar. The difference in age
between these groups was statistically significant,
although a mean age difference of 2 months is likely
clinically irrelevant. These differences could be the
result of one or more factors, including technique of
stage 2 palliation (BDG vs HFP), differences in patient
selection, improved postoperative patient care, reduc-
tion in CPB time and/or aortic crossclamp time, the use
of MUF, or yet other unknown factors. Because of the
nearly concurrent nature of these factors, discerning
those responsible for this improvement in outcome
may not be possible. We favor the notion that the reduc-
tion in CPB and aortic crossclamp time largely
accounts for the improved mortality for several rea-
sons. As previously noted, the trend toward lower mor-
tality in HFP patients operated on by technique II
rather than technique I would suggest that the type of
stage 2 palliation was less important than the type of
surgical technique used for the Fontan operation.
Although patient selection may have tended to elimi-
nate higher-risk patients during the time that technique
Table III. Preoperative and intraoperative variables associated with intubation time
Intubation time Intubation time  
≤3 days >3 days
Parametric data Mean ± CI (range, n) Mean ± CI (range, n) P value
Age (mo) 23.0 ± 1.3 (14-45, 74) 25 ± 3.1 (12-50, 24) >.2
Weight (kg) 10.6 ± 0.37 (7-17, 77) 11.1 ± 0.8 (8.6-15, 23) >.2
SAS (%) 83 ± 1.0 (74-89, 73) 83 ± 2.1 (68-89, 22) >.2
RAP (mm Hg) 63 ± 0.6 (2-16, 69) 6.6 ± 1.3 (0.4-6.2, 20) >.2
PAP (mm Hg) 11.3 ± 0.6 (7-18, 71) 12.0 ± 1.8 (7-17, 22) >.2
PVR (WU × m2) 2.05 ± 0.24 (0.66-4.5, 61) 2.18 ± 0.7 (0.4-6.2, 18) >.2
McGoon ratio 1.51 ± 0.08 (0.86-211, 61) 1.38 ± 0.13 (1.05-1.68, 14) .13
CPB time (min) 76.5 ± 8.2 (43-196, 74) 108.0 ± 9.8 (69-155, 23) .0001
Crossclamp time (min) 44.5 ± 3.7 (24-105, 77) 57.6 ± 6.1 (34-98, 23) .0026
Nonparametric data
Systolic function n = 75 n = 23 >.2*
Normal ventricular function 60 (80%) 17 (74%)
Mild-moderate ventricular dysfunction 11 (15%) 6 (26%)
Severe ventricular dysfunction 4 (5%) 0 (0%)
Tricuspid regurgitation n = 73 n = 24 >.2*
No regurgitation 45 (62%) 15 (63%)
Mild regurgitation 20 (27%) 7 (29%)
Moderate regurgitation 4 (5.5%) 1 (4%)
Severe regurgitation 4 (5.5%) 1 (4%)
Collateral blood flow n = 62 n = 15 >.2*
0 8 (13%) 2 (13%)
1 14 (23%) 6 (40%)
2 22 (35%) 4 (27%)
3 10 (16%) 2 (13%)
4 5 (9%) 1 (7%)
5 2 (3%) 0 (0%)
6 1 (2%) 0 (0%)
Degree of association of preoperative and intraoperative variables with intubation time. Prolonged intubation time was highly associated with longer cardiopulmonary
bypass and aortic crossclamp time. CI, Confidence interval; SAS, systemic arterial saturation; RAP, right atrial pressure; PAP, pulmonary artery pressure; PVR, pul-
monary vascular resistance; WU, Wood units; CPB, cardiopulmonary bypass.
*Statistical testing with Wilcoxon rank sum test.
†Preoperative values.
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II was being used, we have not consciously modified
our selection criteria for the Fontan operation, and the
preoperative characteristics of the patients in the tech-
nique I and II groups were nearly identical (Table I).
Similarly, we have not made any changes in postopera-
tive management that likely account for the difference
in mortality. Other investigators have found longer
CPB and crossclamp times to correlate with less favor-
able outcomes in the patient requiring the Fontan oper-
ation.3,4,22 Given the marked sensitivity of the Fontan
patient to reduced ventricular compliance and
increased pulmonary vascular resistance, both of which
can be caused by CPB and myocardial ischemia relat-
ed to a period aortic crossclamping, it is not surprising
that these factors may adversely affect outcome. Of
note, despite a period of circulatory arrest, technique II
resulted in a significantly shorter duration of CPB.
Recently, hypothermic low-flow CPB has been report-
ed to produce greater pulmonary dysfunction than peri-
ods of circulatory arrest.23 Perhaps reducing this period
of CPB increases lung compliance in patients undergo-
ing technique II, thereby improving their postoperative
course. Importantly, although our technique involves a
period of circulatory arrest, we do not want to suggest
that circulatory arrest imparts any survival advantage.
The use of a single atrial cannula and circulatory arrest
has significantly simplified the procedure, but given the
potential risks associated with its use, we have tried to
minimize the periods of complete circulatory arrest.
Currently, we use brief periods of circulatory arrest and
perform the majority of the procedure with reduced-
flow sucker bypass.
Right ventricular function, as assessed by preopera-
tive right atrial pressure and a subjective echocardio-
graphic estimate of systolic function, did not prove to be
a predictor of survival. It is possible that this is a reflec-
Table IV.  Preoperative and intraoperative variables associated with length of ICU stay
ICU stay ≤ 7 days ICU stay > 7 days ICU stay
Parametric data Mean ± CI (range, n) Mean ± CI (range, n) P value
Age (mo)† 23 ± 1.3 (14-45, 73) 24.8 ± 2.9 (18-50, 26) >.2
Weight (kg)† 10.6 ± 0.4 (8.4-17, 73) 10.9 ± 0.8 (7-15, 25) >.2
SAS (%)† 83 ± 1.0 (74-93, 72) 82 ± 3 (68-89, 24) >.2
RAP (mm Hg)† 6.4 ± 0.6 (2-16, 68) 6.5 ± 1.3 (1-14, 22) >.2
PAP (mm Hg)† 11.5 ± 0.6 (7-18, 71) 11.5 ± 1.2 (7-17, 24) >.2
PVR (WU × m2)† 2.0 ± 0.2 (0.66-4.5, 61) 2.3 ± 0.7 (0.40-6.2, 19) >.2
McGoon ratio† 1.52 ± 0.08 (0.86-2.11, 61) 1.33 ± 0.13 (1.05-1.97, 15) .09
CPB time (min) 76.0 ± 8.0 (43-196, 73) 109.0 ± 9.8 (69-157, 25) <.0001
Crossclamp time (min) 44.0 ± 3.7 (24-105, 73) 57.6 ± 6.9 (34-98, 25) .0009
Nonparametric data
Systolic function† n = 73 n = 25 >.2*
Normal ventricular function 59 (81%) 18 (72%)
Mild-moderate ventricular dysfunction 10 (14%) 7 (28%)
Severe ventricular dysfunction 4 (5%) 0 (0%)
Tricuspid regurgitation† n = 73 n = 25 >.2*
No regurgitation 45 (62%) 15 (60%)
Mild regurgitation 19 (26%) 8 (32%)
Moderate regurgitation 4 (5%) 2 (8%)
Severe regurgitation 5 (7%) 0 (0%)
Collateral blood flow† n = 58 n = 16 >.2*
0 8 (14%) 1 (6%)
1 14 (24%) 6 (38%)
2 19 (33%) 5 (31%)
3 10 (17%) 2 (13%)
4 4 (7%) 2 (13%)
5 2 (3%) 0 (0%)
6 1 (2%) 0 (0%)
Degree of association of preoperative and intraoperative variables with length of stay in the intensive care unit. Prolonged intensive care unit stay was associated with
longer cardiopulmonary bypass and aortic crossclamp times. ICU, Intensive care unit; CI, confidence interval; SAS, Systemic arterial saturation; RAP, right atrial pres-
sure; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance; WU, Wood units; CPB, cardiopulmonary bypass.
*Statistical testing with Wilcoxon rank sum test.
†Preoperative values.
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tion of selection bias (that patients with poor function
did not undergo Fontan palliation). However, in this
series 21 patients estimated to have moderately to
severely depressed function were operated on, and 20
survived. Thus, moderate degrees of right ventricular
dysfunction may be well tolerated at least in the short to
intermediate term. During the time period of the study
only 2 patients underwent cardiac transplantation after
an HFP: one with moderate right ventricular dysfunc-
tion, moderate to severe tricuspid regurgitation, and ele-
vated pulmonary vascular resistance, and the second
with moderate right ventricular dysfunction and bilater-
al pulmonary artery stenoses after bilateral endoluminal
stent placement. In both cases it was the combination of
right ventricular dysfunction with another perceived risk
factor that fostered the decision to proceed with trans-
plantation. Both of these patients are alive and doing
well after their transplant operations.
The degree of preoperative tricuspid regurgitation
also did not have a significant effect on survival. This
may be due to selection bias (only 11 patients had mod-
erate to severe tricuspid regurgitation) and perhaps an
aggressive policy of performing tricuspid valvuloplas-
ty at the time of the Fontan procedure for all but mini-
mal degrees of regurgitation.24 Pulmonary artery size
appears to influence survival in some but not all previ-
ous reports25-27 and did not predict survival in our
series. This may be related in part to the routine bilat-
eral augmentation of the pulmonary arteries at the HFP,
which resulted in adequate-sized pulmonary arteries
for the vast majority of patients at the Fontan proce-
dure. In addition, the use of intravascular pulmonary
artery stents at the Fontan operation may also have
reduced preoperative pulmonary artery size as a risk
factor. Our data also suggest that the magnitude of aor-
topulmonary collateral blood flow is not a significant
Table V. Preoperative and intraoperative variables associated with length of hospital stay
Hospital stay ≤ 16 days Hospital stay > 16 days
Parametric data Mean ± CI (range, n) Mean ± CI (range, n) P value
Age (mo) 22.9 ± 1.4 (14-45, 68) 24.8 ± 2.4 (17-50, 32) .15
Weight (kg) 10.3 ± 0.33 (7-14.5, 70) 11.5 ± 0.7 (8.6-17, 30) .007
SAS (%) 83 ± 1.0 (74-93, 67) 82 ± 2.0 (68-88, 29) >.2
RAP (mm Hg) 6.3 ± 0.7 (2-16.0, 63) 6.6 ± 1.0 (1-14, 27) >.2
PAP (mm Hg) 11.5 ± 0.6 (7-18, 65) 11.6 ± 1.0 (7-17.0, 29) >.2
PVR (WU × m2) 2.1 ± 0.3 (0.4-4.2, 57) 2.2 ± 0.5 (1.1-6.2, 23) >.2
McGoon ratio 1.5 ± 0.09 (0.86-2.11, 54) 1.5 ± 0.10 (1.1-1.87, 22) >.2
CPB time (min) 79.0 ± 8.2 (45-196, 68) 95 ± 12.9 (43-172, 31) .05
Crossclamp time (min) 46.2 ± 3.8 (24-98, 68) 51.5 ± 6.5 (29-105, 31) .16
Nonparametric data
Systolic function n = 67 n = 31 >.2*
Normal ventricular function 51 (76%) 26 (84%)
Mild-moderate ventricular dysfunction 12 (18%) 5 (16%)
Severe ventricular dysfunction 4 (6%) 0 (0%)
Tricuspid regurgitation n = 67 n = 30 >.2*
No regurgitation 41 (61%) 19 (63%)
Mild regurgitation 17 (25%) 9 (30%)
Moderate regurgitation 4 (6%) 2 (7%)
Severe regurgitation 5 (7%) 0 (0%)
Collateral blood flow n = 54 n = 21 >.2*
0 7 (13%) 2 (10%)
1 16 (29%) 4 (19%)
2 15 (28%) 10 (48%)
3 10 (19%) 2 (10%)
4 3 (6%) 3 (14%)
5 2 (4%) 0 (0%)
6 1 (2%) 0 (0%)
Analysis of variables associated with total hospital stay. Total hospital stay was associated with longer cardiopulmonary bypass time. In addition, a statistically sig-
nificant but likely clinically unimportant association of preoperative weight with hospital stay was found. CI, Confidence interval; SAS, systemic arterial saturation;
RAP, right atrial pressure; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance; WU, Wood units; CPB, cardiopulmonary bypass.
*Statistical testing with Wilcoxon rank sum test.
short-term risk factor for Fontan patients. However, the
method used to estimate this flow was crude and this
question requires more quantitative exploration.
Unfortunately, we do not know what effect MUF may
have had on outcomes in these patients. It is possible
that the use of MUF improved outcomes, perhaps by
reducing extravascular fluid or reducing circulating
inflammatory mediators.28-30 We began using MUF in
April 1996; hence, almost all of the technique II group
and none of the technique I group had been treated with
this modality. We cannot therefore separate the possible
confounding effect of MUF from differences related to
surgical technique.
In conclusion, survival after the Fontan procedure for
patients with HLHS has improved markedly and is
equivalent to the results for other univentricular lesions.
The potential negative effects of pulmonary artery
size can be ameliorated, at least in the case of the sur-
gically accessible pulmonary arteries, by the routine
augmentation of the pulmonary arteries at the time of
the HFP or with the use of endoluminal stents.
Tricuspid regurgitation should be aggressively treated
and, if surgically remediable, does not unduly increase
the risk of the Fontan procedure.
R E F E R E N C E S
1. Mair DD, Hagler DJ, Puga FJ, et al. Fontan operation in 176
patients with tricuspid atresia: results and a proposed new index
for patient selection. Circulation 1990;82(Suppl):IV-164-9.
2. Mayer JE Jr, Bridges N, Lock K, et al. Extending the limits for
the modified Fontan procedure. J Thorac Cardiovasc Surg
1986;92:1021-8.
3. Mayer JE Jr, Bridges N, Lock K, et al. Factors associated with
marked reduction in mortality for Fontan operations in patients
with single ventricle. J Thorac Cardiovasc Surg 1992;103:444-
52.
4. Gentles TL, Mayer JE Jr, Gauvreau K, et al. Fontan operation in
five hundred consecutive patients: factors influencing early and
late outcome. J Thorac Cardiovasc Surg 1997;114:379-91.
5. Cetta F, Feldt RH, O’Leary PW, et al. Improved early morbidity
and mortality after the Fontan operation: The Mayo Clinic expe-
rience, 1989 to 1992. J Am Cardiol 1996;28:480-6.
6. Gentles TL, Gauvreau K, Mayer JE Jr, et al. Functional outcome
after the Fontan operation: factors influencing late morbidity. J
Thorac Cardiovasc Surg 1997;114:392-403.
7. Knott-Craig, Danielson GK, Schaff HV, et al. The modified
Fontan operation: an analysis of risk factors for early postopera-
tive death or takedown in 702 consecutive patients from one insti-
tution. J Thorac Cardiovasc Surg 1995;109:1237-43.
8. Caspi C, Coles JG, Rabinovich M, et al. Morphological findings
contributing to a failed Fontan procedure. Circulation
1990;82(Suppl):IV-177-82.
9. Kaulitz R, Ziemer G, Luchmer I, et al. Modified Fontan operation
in functionally univentricular hearts: preoperative risk factors and
intermediate results. J Thorac Cardiovasc Surg 1996;112:658-69.
10. Ichikawa H, Yagihara T, Kishimoto H, et al. Extent of aortopul-
monary collateral blood flow as a risk factor for Fontan opera-
tions. Ann Thorac Surg 1995;59:433-7.
11. Spicer RL, Uzark KC, Moore JW, et al. Aortopulmonary collat-
eral vessels and prolonged pleural effusions after modified
Fontan procedures. Am Heart J 1996;131:1164-8.
12. Bove EL, Lloyd TR. Staged reconstruction for hypoplastic left
heart syndrome. Ann Surg 1996;224:387-95.
13. Haller JA, Adkins JC, Worthington M, et al. Experimental stud-
ies on permanent bypass of the right heart. Surgery
1966;59:1128-32.
14. Hopkins RA, Armstrong BE, Serwer GA, et al. Physiologic ratio-
nale for a bidirectional cavopulmonary shunt: a versatile comple-
ment to the Fontan procedure. J Thorac Cardiovasc Surg
1985;90:391-8.
15. Douville EC, Sade RM, Fyfe DA. Hemi-Fontan operation in
surgery for single ventricle: a preliminary report. Ann Thorac
Surg 1991;51:893-900.
16. Bove EL, Mosca RS. Surgical repair of the hypoplastic left heart
syndrome. Prog Pediatr Cardiol 1996;5:23-5.
17. Mosca RS, Bove EL. Tricuspid valvuloplasty in patients with
hypoplastic left heart syndrome. Semin Cardiothorac Surg. (In
press).
18. Naik SK, Knight A, Elliott M. A prospective randomized study of
a modified technique of ultrafiltration during pediatric open heart
surgery. Circulation 1991;84(5 Suppl):III-422-31.
19. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric
open heart operations. Ann Thorac Surg 1993;56:1518-22.
20. Piehler MJ, Danielson GK, McGoon DC, et al. Management of
pulmonary atresia with ventricular septal defect and hypoplastic
pulmonary arteries by right ventricular outflow construction. J
Thorac Cardiovasc Surg 1979;80:555-62.
21. Blackstone EH, Kirklin JW, Bertranou EG, et al. Preoperative
prediction from cineangiograms of right ventricular pressure in
tetralogy of Fallot. J Thorac Cardiovasc Surg 1979;78:542-52.
22. Petrossian E, Reddy VM, McElhinney DB, et al. Early results of
the extracardiac conduit Fontan operation. J Thorac Cardiovasc
Surg 1999;117:688-96.
23. Skaryak LA, Lodge AJ, Kirshbom PM, et al. Low-flow car-
diopulmonary bypass produces greater pulmonary dysfunction
than circulatory arrest. Ann Thorac Surg 1996;62:1284-8.
24. Reyes A II, Bove EL, Mosca RS, Kulik TJ, Ludomirsky A.
Tricuspid valve repair in children with hypoplastic left heart syn-
drome during staged surgical reconstruction. Circulation
1997;96:(Suppl 9):II-341-3.
25. Girod D, Rice M, Mair D, et al. Relationship of pulmonary artery
size to mortality in patients undergoing the Fontan operation.
Circulation 1985;72(Suppl):II-93-6.
26. Bridges ND, Farrell PE Jr, Pigott JD 3d, Norwood WI, Chin AJ.
Pulmonary artery index: a nonpredictor of operative survival in
patients undergoing modified Fontan repair. Circulation
1989;80(Suppl):I-216-21.
27. Senzaki H, Isoda T, Ishizawa A, et al. Reconsideration of criteria
for the Fontan operation: influence of pulmonary artery size on
postoperative hemodynamics of the Fontan operation.
Circulation 1994;89:266-71.
28. Wan S, LeClerc JL, Vincent JL. Inflammatory response to car-
diopulmonary bypass: mechanisms involved and possible thera-
peutic strategies. Chest 1997;112:676-92.
29. Saatvedt K, Lindberg H, Geiran OR, et al. Ultrafiltration after
cardiopulmonary bypass in children: effects on hemodynamics,
cytokines and complement. Cardiovasc Res 1996;31:596-602.
30. Koutlas JC, Gaynor JW, Nicolson SC, et al. Modified ultrafiltra-
tion reduces postoperative morbidity after cavopulmonary con-
nection. Ann Thorac Surg 1997;64:37-43.
1118 Mosca et al The Journal of Thoracic and
Cardiovascular Surgery
June 2000
